PortfoliosLab logoPortfoliosLab logo
CNC vs. HCA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CNC vs. HCA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Centene Corporation (CNC) and HCA Healthcare, Inc. (HCA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CNC achieves a 44.71% return, which is significantly higher than HCA's -22.08% return. Over the past 10 years, CNC has underperformed HCA with an annualized return of 6.23%, while HCA has yielded a comparatively higher 17.50% annualized return.


CNC

1D
-0.73%
1M
11.18%
YTD
44.71%
6M
53.44%
1Y
7.55%
3Y*
-3.59%
5Y*
-3.58%
10Y*
6.23%

HCA

1D
-1.12%
1M
-14.97%
YTD
-22.08%
6M
-25.16%
1Y
-4.54%
3Y*
10.68%
5Y*
12.13%
10Y*
17.50%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CNC vs. HCA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CNC
Centene Corporation
44.71%-32.07%-18.37%-9.51%-0.47%37.26%-4.52%9.05%14.29%78.52%
HCA
HCA Healthcare, Inc.
-22.08%56.71%11.75%13.83%-5.64%57.58%12.07%20.24%43.37%18.67%

Correlation

The correlation between CNC and HCA is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (10Y)
Calculated over the trailing 10-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Mar 11, 2011

0.38

The correlation between CNC and HCA shifts across timeframes, from 0.21 (1 year) to 0.40 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

CNC:

-$13.07

HCA:

$28.46

PS Ratio

CNC:

0.15

HCA:

1.15

Total Revenue (TTM)

CNC:

$198.10B

HCA:

$75.60B

Gross Profit (TTM)

CNC:

$29.57B

HCA:

$31.37B

EBITDA (TTM)

CNC:

-$5.11B

HCA:

$15.60B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CNC vs. HCA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNC
CNC Risk / Return Rank: 4545
Overall Rank
CNC Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
CNC Sortino Ratio Rank: 4444
Sortino Ratio Rank
CNC Omega Ratio Rank: 5050
Omega Ratio Rank
CNC Calmar Ratio Rank: 4343
Calmar Ratio Rank
CNC Martin Ratio Rank: 4242
Martin Ratio Rank

HCA
HCA Risk / Return Rank: 3232
Overall Rank
HCA Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
HCA Sortino Ratio Rank: 2828
Sortino Ratio Rank
HCA Omega Ratio Rank: 2828
Omega Ratio Rank
HCA Calmar Ratio Rank: 3636
Calmar Ratio Rank
HCA Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNC vs. HCA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Centene Corporation (CNC) and HCA Healthcare, Inc. (HCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CNCHCADifference
Sharpe ratioReturn per unit of total volatility

+0.29

Sortino ratioReturn per unit of downside risk

+0.65

Omega ratioGain probability vs. loss probability

1.11

0.99

+0.12

Calmar ratioReturn relative to maximum drawdown

0.14

-0.14

+0.27

Martin ratioReturn relative to average drawdown

0.22

-0.46

+0.69

CNC vs. HCA - Sharpe Ratio Comparison

The current CNC Sharpe Ratio is 0.12, which is higher than the HCA Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of CNC and HCA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CNCHCADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.12

-0.17

+0.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.09

0.41

-0.50

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

0.54

-0.38

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

0.60

-0.21

Drawdowns

CNC vs. HCA - Drawdown Comparison

The maximum CNC drawdown since its inception was -74.07%, which is greater than HCA's maximum drawdown of -54.74%. Use the drawdown chart below to compare losses from any high point for CNC and HCA.


Loading charts...

Drawdown Indicators


CNCHCADifference

Max Drawdown

Largest peak-to-trough decline

-74.07%

-54.74%

-19.33%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-33.27%

-22.23%

Max Drawdown (3Y)

Largest decline over 3 years

-68.65%

-33.27%

-35.38%

Max Drawdown (5Y)

Largest decline over 5 years

-74.07%

-39.49%

-34.58%

Max Drawdown (10Y)

Largest decline over 10 years

-74.07%

-54.74%

-19.33%

Current Drawdown

Current decline from peak

-38.75%

-33.27%

-5.48%

Average Drawdown

Average peak-to-trough decline

-22.14%

-11.01%

-11.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.84%

9.85%

+23.99%

Volatility

CNC vs. HCA - Volatility Comparison

Centene Corporation (CNC) has a higher volatility of 10.45% compared to HCA Healthcare, Inc. (HCA) at 6.36%. This indicates that CNC's price experiences larger fluctuations and is considered to be riskier than HCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CNCHCADifference

Volatility (1M)

Calculated over the trailing 1-month period

10.45%

6.36%

+4.09%

Volatility (6M)

Calculated over the trailing 6-month period

36.05%

21.12%

+14.93%

Volatility (1Y)

Calculated over the trailing 1-year period

64.10%

26.90%

+37.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.40%

29.80%

+9.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.48%

32.60%

+5.88%

Dividends

CNC vs. HCA - Dividend Comparison

CNC has not paid dividends to shareholders, while HCA's dividend yield for the trailing twelve months is around 0.81%.


PositionTTM20252024202320222021202020192018
CNC
Centene Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HCA
HCA Healthcare, Inc.
0.81%0.62%0.88%0.89%0.93%0.75%0.63%1.08%1.12%

Financials

CNC vs. HCA - Financials Comparison

This section allows you to compare key financial metrics between Centene Corporation and HCA Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B20.00B30.00B40.00B50.00B20222023202420252026
49.94B
19.51B
(CNC) Total Revenue
(HCA) Total Revenue
Values in USD except per share items

CNC vs. HCA - Profitability Comparison

The chart below illustrates the profitability comparison between Centene Corporation and HCA Healthcare, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
21.9%
41.9%
Portfolio components
CNC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Centene Corporation reported a gross profit of 10.94B and revenue of 49.94B. Therefore, the gross margin over that period was 21.9%.

HCA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a gross profit of 8.18B and revenue of 19.51B. Therefore, the gross margin over that period was 41.9%.

CNC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Centene Corporation reported an operating income of 1.86B and revenue of 49.94B, resulting in an operating margin of 3.7%.

HCA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported an operating income of 3.18B and revenue of 19.51B, resulting in an operating margin of 16.3%.

CNC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Centene Corporation reported a net income of 1.54B and revenue of 49.94B, resulting in a net margin of 3.1%.

HCA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a net income of 1.88B and revenue of 19.51B, resulting in a net margin of 9.6%.


Frequently Asked Questions


CNC and HCA have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CNC has higher volatility (10.45%) compared to HCA (6.36%). In terms of maximum drawdown, CNC dropped -74.07% vs HCA's -54.74%.

CNC currently has the higher Sharpe Ratio (0.12 vs -0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CNC and HCA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer